Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected Non Small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00484016

Enrollment

Registered

2007-06-08

Start date

2006-02-28

Completion date

2007-04-30

Last updated

2013-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjuvant, Cancers, Chemotherapy, Lung

Keywords

adjuvant, chemotherapy, observation, resected, cancers

Brief summary

There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.

Detailed description

We propose to retrospectively examine the Washington University School of Medicine experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will retrospectively analyze the survival and outcomes in the lung cancer patients receiving adjuvant chemotherapy following surgical resection.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 88 Years

Healthy volunteers

Inclusion criteria

* Patients that received adjuvant chemotherapy * 18-88 years

Exclusion criteria

* Any patients that have not received adjuvant chemotherapy * Patients under 18 or over 88

Outcome results